Pelletier Saundra L
- SEC CIK
- 0001251371
No open-market purchases or sales filed in the past year.
Current role at each company
- EVFM Evofem Biosciences, Inc.Chief Executive Officeras of Apr 26, 2023
- TCON Tracon Pharmaceuticals, Inc.Directoras of Apr 21, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Pelletier Saundra L as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
EVFM Evofem Biosciences, Inc.
Chief Executive Officer2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 31, 2022 (view filing)8:55 AM ET | May 27 | 4 days | Pelletier Saundra LChief Executive Officer | PPurchase | +141.0K | $0.3525 | +$49.7K | +147.3%236.7K after | |
| Dec 20, 2021 (view filing)4:19 PM ET | Dec 20 | Same day | Pelletier Saundra LChief Executive Officer | PPurchase | +135.0K | $0.375 | +$50.6K | +15.9%985.8K after |
TCON Tracon Pharmaceuticals, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 27, 2021 (view filing) | Jul 26 | 1 day | Pelletier Saundra LDirector | PPurchase | +6.54K | $3.82 | +$25.0K | +119.0%12.0K after |